Jérôme Biton

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

Elisa Peranzoni, Jean Lemoine, Lene Vimeux et al. · Proceedings of the National Academy of Sciences · 2018 · 892 citations · Full text

<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

Jérôme Biton, Audrey Mansuet‐Lupo, Nicolas Pécuchet et al. · Clinical Cancer Research · 2018 · 348 citations

Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

Jitka Fučíková, Étienne Becht, Kristina Iribarren et al. · Cancer Research · 2016 · 185 citations

Immunology, Pathology, Cell Death +18

Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer

Marco Alifano, Audrey Mansuet‐Lupo, Filippo Lococo et al. · PLoS ONE · 2014 · 170 citations · Full text

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Diane Damotte, Sarah Warren, Jennifer Arrondeau et al. · Journal of Translational Medicine · 2019 · 145 citations · Full text